Nanomix Awarded SBIR Grant From National Institute of Health; Focused on Novel Manufacturing Techniques for the Sensation(TM) Nanoelectronic Detection Platform
"By strongly supporting process improvement related to Sensation(TM) technology, this project will enhance development of key medical applications," said Dr. Jean-Christophe Gabriel, the principal investigator on the NIH-sponsored project. "It also enables Nanomix to leverage the know-how available at the National Institute of Biomedical Imaging and Bioengineering."
“By strongly supporting process improvement related to Sensation(TM) technology, this project will enhance development of key medical applications”
"Receiving this grant demonstrates the value and promise of our innovative manufacturing processes," said David Macdonald, President and CEO of Nanomix. "We believe we are the clear leader in bringing nanoelectronic products to the marketplace, and are encouraged by our success at procuring this type of support."
Nanomix is launching a portfolio of devices based on Sensation(TM) detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistries. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanodetection technology -- low power consumption, small form factor, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California. For additional information, please visit the Nanomix web site at www.nano.com.